Purpose: To evaluate the rate of delayed or missed diagnoses and need for additional computed tomography (CT) imaging in emergency department patients with abdominal pain who are imaged without oral contrast.

Materials And Methods: The institutional review board approved this Health Insurance Portability and Accountability Act-compliant retrospective study; informed consent was waived. All consecutive adult patients with body mass index greater than 25 undergoing a CT abdomen/pelvis with intravenous contrast and without oral contrast with nontraumatic acute abdominal pain during a 16-month period at our academic tertiary care center were included. Medical records were reviewed, imaging findings on admission CT, use of repeat CT examinations within 4 weeks of the original examination, and clinical outcomes were recorded. In patients undergoing repeat imaging, an investigator determined whether repeat imaging was influenced by the lack of oral contrast on the original examination. As the most common cause of bowel-related positive CT scans, an analysis of acute appendicitis was performed.

Results: Of the 1992 patients included in this study, 4 patients (0.2%) underwent repeat CT studies directly related to the absence of oral contrast on the original examination. Of the 1992 CT scans, 1193(59.8%) were interpreted as negative, none of which required surgery or direct intervention. In patients with acute appendicitis, there was a sensitivity of CT in this patient population of 100% with a specificity of 99.5%.

Conclusions: In patients with body mass index greater than 25 presenting to the ED with acute abdominal pain, CT examinations can be acquired without oral contrast without compromising the clinical efficacy of CT.

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000277DOI Listing

Publication Analysis

Top Keywords

oral contrast
20
abdominal pain
16
acute abdominal
12
patients body
12
body mass
12
mass greater
12
original examination
12
computed tomography
8
patients
8
repeat imaging
8

Similar Publications

Non-medicinal oral contrast in upper abdominal MRI for MR-guided radiotherapy: A scoping review.

Radiography (Lond)

January 2025

Radiotherapy, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, UK; Leeds Institute of Medical Research, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds, UK.

Introduction: Using non-medicinal oral contrast agents may aid safe delivery of magnetic resonance image-guided (MR-guided) radiotherapy by improving the ability to visualise and avoid excessive radiation dose to adjacent bowel/stomach. This scoping review aims to map the literature on non-medicinal oral contrasts used in upper-abdominal diagnostic or therapeutic magnetic resonance imaging (MRI) to find potential candidates for employing in MR-guided radiotherapy and identify gaps in knowledge for further study.

Methods: A scoping review of non-medicinal oral contrast used in upper-abdominal MRI research followed a pre-defined protocol based on Arksey and O'Malley's framework.

View Article and Find Full Text PDF

Aim: The World Health Organization reported that cancer was the cause of death for 9.7 million people in 2022, and the numbers continue to rise every day. The present study examines the potential radioprotective effects of ubiquinone against x-ray radiation-induced intestinal damage and offers insight into new near-future methods for the treatment of radiation-induced tissue toxicity.

View Article and Find Full Text PDF

Bisphenol A (BPA) is a hazardous endocrine disruptor released into the environment during the production of certain plastics used for covering of food and beverage cans. In this work, we examined the protective benefits of selenium (Se) against intestinal damage induced by BPA in male rats. Rats were distributed randomly into four groups.

View Article and Find Full Text PDF

: is the leading cause of chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosal-associated lymphoma. Due to the emerging problems with antibiotic treatment against in clinical practice, vaccination has gained more interest. Oral immunization is considered a promising approach for preventing initial colonization of this bacterium in the gastrointestinal tract, establishing a first line of defense at gastric mucosal surfaces.

View Article and Find Full Text PDF

Microneedle(MN)-based drug delivery is one of the potential approaches to overcome the limitations of oral and hypodermic needle delivery. An in silico model has been developed for hollow microneedle (HMN)-based drug delivery in the skin and its subsequent absorption in the blood and tissue compartments in the presence of interstitial flow. The drug's reversible specific saturable binding to its receptors and the kinetics of reversible absorption across the blood and tissue compartments have been taken into account.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!